4-HO-MPT

4-HO-MPT
Names
	Preferred IUPAC name 3-{2-[Methyl(propyl)amino]ethyl}-1H-indol-4-ol
Identifiers
CAS Number	763035-03-6 (Free base) ; 77872-42-5 (Hydrochloride) ;
3D model ( JSmol)	Interactive image;
ChemSpider	10513074 ;
PubChem CID	21786584;
UNII	37A55H0XW4;
CompTox Dashboard (EPA)	DTXSID90904008 ;
	InChI InChI=1S/C14H20N2O/c1-3-8-16(2)9-7-11-10-15-12-5-4-6-13(17)14(11)12/h4-6,10,15,17H,3,7-9H2,1-2H3 Key: XFQDDPQGBLSNCN-UHFFFAOYSA-N ; InChI=1S/C14H20N2O/c1-3-8-16(2)9-7-11-10-15-12-5-4-6-13(17)14(11)12/h4-6,10,15,17H,3,7-9H2,1-2H3 Key: XFQDDPQGBLSNCN-UHFFFAOYAC;
	SMILES OC1=CC=CC2=C1C(CCN(C)CCC)=CN2;
Properties
Chemical formula	C14H20N2O
Molar mass	232.327 g·mol−1
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). verify (what is ?) Infobox references

4-Hydroxy-N-methyl-N-propyltryptamine, commonly known as 4-HO-MPT or meprocin, is a

MPT

.

History

4-HO-MPT was first synthesized and bioassayed by biochemist Alexander Shulgin and written about in his 1994 book TiHKAL.^[1]

Dosage and duration

For psychedelic effects, the dosage and duration are listed as "unknown" in TiHKAL.^[1]

Effects

Very little data exists about the pharmacological properties, metabolism, and toxicity of 4-HO-MPT. In a single trial of 8 mg orally of 4-HO-MPT HCl from TiHKAL, it is described as producing visual distortion,

vertigo, and slight insomnia.^[1]